Manufactures and sells fertilizers, crop protection chemicals and specialty nutrients, with operations across 18 manufacturing facilities in India and exports to 46 countries. The Nutrient and other allied business segment generated 90.1% of segment revenue (₹276.93 cr as per the period covered by F_SEGMENTS), consisting of phosphatic fertilizers, specialty and secondary nutrients, and bio products; the company holds 22% primary fertilizer market share and was India's largest phosphatic fertilizer company by sales volume for a second consecutive year. The Crop protection segment contributed 9.9% of segment revenue (₹30.54 cr), supplying agrochemical formulations and active ingredients; in Q1 FY27 it posted record results with segment revenue +20% YoY to ₹870 cr and EBIT +44% to ₹159 cr, led by exports and B2B. A retail network of 1,200+ outlets sells inputs and farm advisory directly to farmers, with 76% of stores profitable in Q1 FY27 versus 61% a year earlier and revenue +85% YoY. Backward integration includes a Senegal rock phosphate mine (BMCC, 1.1 lakh tons produced) plus newly commissioned phosphoric and sulphuric acid plants at Kakinada, with 750 kt of granulation capacity targeted for Q4 FY27 commissioning. Materials — sulphur, ammonia, rock phosphate — are the largest cost at 54.7% of revenue, and fertilizer selling prices are largely set under the government's Nutrient Based Subsidy framework, with ₹3,254 cr of subsidy outstanding as of 30 June 2026. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Nutrient and other allied business (90%), Crop protection (10%). Asset-heavy, subsidy-linked fertilizer manufacturing with crop protection and retail diversification
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 19,111 | 29,628 | 22,058 | 24,085 | 31,480 |
| EBITDA (ex other income) | 2,150 | 2,926 | 2,399 | 2,975 | 3,146 |
| margin % | 11.2 | 9.9 | 10.9 | 12.4 | 10.0 |
| Owners' profit | 1,528 | 2,013 | 1,642 | 2,066 | 1,956 |
| EPS, as reported (₹) | 52.09 | 68.51 | 55.81 | 70.23 | 66.41 |
| ROE % · ROCE % | 24.0 · 31.1 | 25.5 · 34.8 | 17.4 · 24.0 | 18.3 · 25.5 | 14.5 · 21.1 |
| Debt / equity (x) | 0.00 | 0.00 | 0.01 | 0.02 | 0.07 |
| Cash from operations | 1,054 | 1,615 | 1,358 | 970 | 1,558 |
| Capex | (278) | (605) | (527) | (851) | (1,540) |
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7,433 | 6,935 | 4,988 | 7,042 | 9,654 | 8,779 | 6,004 | 8,165 |
| Profit before tax | 905 | 692 | 747 | 677 | 1,059 | 653 | 228 | 514 |
| Net profit | 659 | 508 | 578 | 502 | 793 | 488 | 115 | 382 |
| EPS (₹) | 22.57 | 17.39 | 19.70 | 17.15 | 27.34 | 17.17 | 4.75 | 12.93 |
| Segment | Revenue, ₹ crore | Share % |
|---|---|---|
| Nutrient and other allied business | 27,727 | 87.5 |
| Crop protection | 3,968 | 12.5 |
| Total, before eliminations | 31,695 | 100.0 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| COROMANDEL INTERNTL. LTD ◆ | 57,080 | 31.1 | 4.35 | 16.5 | 14.5 | 18.6 | 17.2 | 9.9 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 2 Sept 2026 · Coromandel converts Rs 108 Cr loan into equity in wholly owned subsidiary | strategic transactions | medium | — | — |
| 24 Aug 2026 · Subsidiary Dhaksha opens new drone manufacturing facility in Kancheepuram | capex operations | medium | — | — |
| 21 Aug 2026 · Allotment of 44,460 equity shares under ESOP Scheme 2016 | capital market events | low | — | — |
| 21 Aug 2026 · GST appeal order for FY19 tax demand of about Rs 1.24 crore | regulatory legal | high | — | — |
| 31 Jul 2026 · Coromandel Q1FY27 earnings call transcript filed - revenue up 15%, profit down | investor communications | medium | — | — |
| 24 Jul 2026 · Audio recording of Q1 FY27 analyst call uploaded to website | investor communications | low | — | — |
| 24 Jul 2026 · AGM voting results: all 6 resolutions approved | board shareholder meetings | low | — | — |
| 24 Jul 2026 · Coromandel International Q1FY27 investor presentation uploaded | investor communications | medium | — | — |
| 23 Jul 2026 · 64th AGM held on July 23, 2026; final dividend declared, auditor re-appointed | board shareholder meetings | low | — | — |
| 23 Jul 2026 · Q1 FY27: Revenue Up 10%, PAT Falls 26% on Raw Material Costs | compliance | low | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) |
| FACT LTD |
| 50,465 |
| 1813.7 |
| 36.70 |
| 154.9 |
| 1.8 |
| 1.8 |
| — |
| (0.2) |
| CHAMBAL FERTILIZERS LTD | 16,803 | 8.7 | 1.62 | 6.3 | 18.8 | 20.7 | 10.3 | 17.5 |
| PARADEEP PHOSPHATES LTD | 16,216 | 15.1 | 2.39 | 10.1 | 14.7 | 16.5 | — | 12.5 |
| MADHYA BHARAT AGRO P. LTD | 7,021 | 10.9 | 12.77 | — | 27.3 | 16.6 | — | 17.1 |
| GUJ STATE FERT & CHEM LTD | 6,219 | 9.0 | 0.51 | 5.7 | 5.5 | 6.5 | 7.5 | 7.4 |
| RASHTRIYA CHEMICALS & FER | 6,151 | 13.8 | 1.20 | 8.5 | 8.3 | 8.2 | 17.4 | 7.1 |
| KRISHANA PHOSCHEM LIMITED | 5,570 | 7.0 | 9.93 | — | 32.1 | 30.2 | — | 17.9 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 31.1 | 10.9 | 19 of 21 | 10% |
| P/B | 4.3 | 1.0 | 19 of 23 | 18% |
| ROCE | 18.6 | 8.8 | 5 of 23 | 82% |
| ROE | 14.4 | 8.3 | 8 of 23 | 68% |
| Debt / Equity | 0.1 | 0.3 | 4 of 23 | 86% |
| EBITDA margin | 9.9 | 8.0 | 9 of 21 | 60% |
| Revenue growth | 15.9 | 16.3 | 12 of 21 | 45% |
| Profit growth | (23.9) | 6.4 | 20 of 23 | 14% |
| Market cap | 57080 | 929 | 1 of 23 | 100% |
| A state: the latest filed quarter and the measured reactions |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
